Targeting a neoantigen derived from a common TP53 mutation

Hsiue, E; Wright, K.; Douglass, J.; Hwang, M.; Mog, B.; Pearlman, A.; Paul, S.; DiNapoli, S.; Konig, M.; Wang, Q.; Schaefer, A.; Miller, M.; Skora, A.; Azurmendi, P.; Murphy, M.; Liu, Q.; Watson, E.; Li, Y.; Pardoll, D.; Bettegowda, C.; Papadopoulos, N.; Kinzler, K.; Vogelstein, B.; Gabelli, S.; Zhou, S.

doi:10.1126/science.abc8697

Targeting a neoantigen derived from a common TP53 mutation

Journal Article · 01 January 2022 · Science

DOI:https://doi.org/10.1126/science.abc8697· OSTI ID:1783941

Hsiue, E; Wright, K.; Douglass, J.; Hwang, M.; Mog, B.; Pearlman, A.; Paul, S.; DiNapoli, S.; Konig, M.; Wang, Q.; Schaefer, A.; Miller, M.; Skora, A.; Azurmendi, P.; Murphy, M.; Liu, Q.; Watson, E.; Li, Y.; Pardoll, D.; Bettegowda, C. more »

Research Organization:: Brookhaven National Lab. (BNL), Upton, NY (United States)

Sponsoring Organization:: ~OTHER

DOE Contract Number:: SC0012704

OSTI ID:: 1783941

Report Number(s):: BNL-221472-2021-JACI

Journal Information:: Science, Vol. 371, Issue 6533

Country of Publication:: United States

Language:: English

References (80)

Signatures of mutational processes in human cancer Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C. Nature, Vol. 500, Issue 7463 https://doi.org/10.1038/nature12477	journal	August 2013
Cancer Genome Landscapes Vogelstein, B.; Papadopoulos, N.; Velculescu, V. E. Science, Vol. 339, Issue 6127 https://doi.org/10.1126/science.1235122	journal	March 2013
Lessons from the Cancer Genome Garraway, Levi A.; Lander, Eric S. Cell, Vol. 153, Issue 1 https://doi.org/10.1016/j.cell.2013.03.002	journal	March 2013
The evolutionary history of 2,658 cancers Gerstung, Moritz; Jolly, Clemency; Leshchiner, Ignaty Nature, Vol. 578, Issue 7793 https://doi.org/10.1038/s41586-019-1907-7	journal	February 2020
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data: Human Mutation Bouaoun, Liacine; Sonkin, Dmitriy; Ardin, Maude Human Mutation, Vol. 37, Issue 9 https://doi.org/10.1002/humu.23035	journal	July 2016
p53 mutations in human cancers Hollstein, M.; Sidransky, D.; Vogelstein, B. Science, Vol. 253, Issue 5015 https://doi.org/10.1126/science.1905840	journal	July 1991
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers Malekzadeh, Parisa; Pasetto, Anna; Robbins, Paul F. Journal of Clinical Investigation, Vol. 129, Issue 3 https://doi.org/10.1172/JCI123791	journal	January 2019
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer Lo, Winifred; Parkhurst, Maria; Robbins, Paul F. Cancer Immunology Research, Vol. 7, Issue 4 https://doi.org/10.1158/2326-6066.CIR-18-0686	journal	February 2019
Toward a Shared Vision for Cancer Genomic Data Grossman, Robert L.; Heath, Allison P.; Ferretti, Vincent New England Journal of Medicine, Vol. 375, Issue 12 https://doi.org/10.1056/NEJMp1607591	journal	September 2016
Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations González-Galarza, Faviel F.; Takeshita, Louise Y. C.; Santos, Eduardo J. M. Nucleic Acids Research, Vol. 43, Issue D1 https://doi.org/10.1093/nar/gku1166	journal	November 2014
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody Dao, Tao; Yan, Su; Veomett, Nicholas Science Translational Medicine, Vol. 5, Issue 176 https://doi.org/10.1126/scitranslmed.3005661	journal	March 2013
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens Chang, Aaron Y.; Dao, Tao; Gejman, Ron S. Journal of Clinical Investigation, Vol. 127, Issue 7 https://doi.org/10.1172/JCI92335	journal	June 2017
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy Li, Demin; Bentley, Carol; Anderson, Amanda Cancer Research, Vol. 77, Issue 10 https://doi.org/10.1158/0008-5472.CAN-16-3247	journal	March 2017
Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen Low, Lionel; Goh, Angeline; Koh, Joanna Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-019-13305-z	journal	November 2019
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1 Dao, Tao; Pankov, Dmitry; Scott, Andrew Nature Biotechnology, Vol. 33, Issue 10 https://doi.org/10.1038/nbt.3349	journal	September 2015
Prospects for gene-engineered T cell immunotherapy for solid cancers Klebanoff, Christopher A.; Rosenberg, Steven A.; Restifo, Nicholas P. Nature Medicine, Vol. 22, Issue 1 https://doi.org/10.1038/nm.4015	journal	January 2016
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen Rafiq, S.; Purdon, T. J.; Daniyan, A. F. Leukemia, Vol. 31, Issue 8 https://doi.org/10.1038/leu.2016.373	journal	December 2016
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Maude, Shannon L.; Frey, Noelle; Shaw, Pamela A. New England Journal of Medicine, Vol. 371, Issue 16 https://doi.org/10.1056/NEJMoa1407222	journal	October 2014
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia Park, Jae H.; Rivière, Isabelle; Gonen, Mithat New England Journal of Medicine, Vol. 378, Issue 5 https://doi.org/10.1056/NEJMoa1709919	journal	February 2018
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Schuster, Stephen J.; Bishop, Michael R.; Tam, Constantine S. New England Journal of Medicine, Vol. 380, Issue 1 https://doi.org/10.1056/NEJMoa1804980	journal	January 2019
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response Robbins, Paul F.; Kassim, Sadik H.; Tran, Thai L. N. Clinical Cancer Research, Vol. 21, Issue 5 https://doi.org/10.1158/1078-0432.CCR-14-2708	journal	December 2014
Engineering strategies to overcome the current roadblocks in CAR T cell therapy Rafiq, Sarwish; Hackett, Christopher S.; Brentjens, Renier J. Nature Reviews Clinical Oncology, Vol. 17, Issue 3 https://doi.org/10.1038/s41571-019-0297-y	journal	December 2019
Bispecific antibodies: a mechanistic review of the pipeline Labrijn, Aran F.; Janmaat, Maarten L.; Reichert, Janice M. Nature Reviews Drug Discovery, Vol. 18, Issue 8 https://doi.org/10.1038/s41573-019-0028-1	journal	June 2019
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Kantarjian, Hagop; Stein, Anthony; Gökbuget, Nicola New England Journal of Medicine, Vol. 376, Issue 9 https://doi.org/10.1056/NEJMoa1609783	journal	March 2017
Gapped sequence alignment using artificial neural networks: application to the MHC class I system Andreatta, Massimo; Nielsen, Morten Bioinformatics, Vol. 32, Issue 4 https://doi.org/10.1093/bioinformatics/btv639	journal	October 2015
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers Parkhurst, Maria R.; Robbins, Paul F.; Tran, Eric Cancer Discovery, Vol. 9, Issue 8 https://doi.org/10.1158/2159-8290.CD-18-1494	journal	June 2019
Direct Detection and Quantification of Neoantigens Wang, Qing; Douglass, Jacqueline; Hwang, Michael S. Cancer Immunology Research, Vol. 7, Issue 11 https://doi.org/10.1158/2326-6066.CIR-19-0107	journal	September 2019
Bispecific antibodies targeting mutant RAS neoantigens Douglass, Jacqueline; Hsiue, Emily Han-Chung; Mog, Brian J. Science Immunology, Vol. 6, Issue 57 https://doi.org/10.1126/sciimmunol.abd5515	journal	March 2021
TCR β chain–directed bispecific antibodies for the treatment of T cell cancers Paul, Suman; Pearlman, Alexander H.; Douglass, Jacqueline Science Translational Medicine, Vol. 13, Issue 584 https://doi.org/10.1126/scitranslmed.abd3595	journal	March 2021
Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding Wu, H.; Myszka, D. G.; Tendian, S. W. Proceedings of the National Academy of Sciences, Vol. 93, Issue 26 https://doi.org/10.1073/pnas.93.26.15030	journal	December 1996
Distinctive functional characteristics of human „T” lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody Beverley, Peter C. L.; Callard, Robin E. European Journal of Immunology, Vol. 11, Issue 4 https://doi.org/10.1002/eji.1830110412	journal	January 1981
Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab′)2 for efficient lysis of p185HER2 overexpressing tumor cells Zhu, Zhenping; Lewis, Gail D.; Carter, Paul International Journal of Cancer, Vol. 62, Issue 3 https://doi.org/10.1002/ijc.2910620315	journal	July 1995
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody Dreier, Torsten; Lorenczewski, Grit; Brandl, Christian International Journal of Cancer, Vol. 100, Issue 6 https://doi.org/10.1002/ijc.10557	journal	July 2002
Inference of Macromolecular Assemblies from Crystalline State Krissinel, Evgeny; Henrick, Kim Journal of Molecular Biology, Vol. 372, Issue 3 https://doi.org/10.1016/j.jmb.2007.05.022	journal	September 2007
A large peptidome dataset improves HLA class I epitope prediction across most of the human population Sarkizova, Siranush; Klaeger, Susan; Le, Phuong M. Nature Biotechnology, Vol. 38, Issue 2 https://doi.org/10.1038/s41587-019-0322-9	journal	December 2019
Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue Webb, Andrew I.; Dunstone, Michelle A.; Chen, Weisan Journal of Biological Chemistry, Vol. 279, Issue 22 https://doi.org/10.1074/jbc.M314066200	journal	May 2004
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics Ataie, Niloufar; Xiang, Jingyi; Cheng, Neal Journal of Molecular Biology, Vol. 428, Issue 1 https://doi.org/10.1016/j.jmb.2015.12.002	journal	January 2016
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform Gejman, Ron S.; Jones, Heather F.; Klatt, Martin G. Cancer Immunology Research, Vol. 8, Issue 5 https://doi.org/10.1158/2326-6066.CIR-19-0745	journal	March 2020
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes Kula, Tomasz; Dezfulian, Mohammad H.; Wang, Charlotte I. Cell, Vol. 178, Issue 4 https://doi.org/10.1016/j.cell.2019.07.009	journal	August 2019
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide–HLA Complex Coles, Charlotte H.; Mulvaney, Rachel M.; Malla, Sunir The Journal of Immunology, Vol. 204, Issue 7 https://doi.org/10.4049/jimmunol.1900915	journal	February 2020
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules Harper, Jane; Adams, Katherine J.; Bossi, Giovanna PLOS ONE, Vol. 13, Issue 10 https://doi.org/10.1371/journal.pone.0205491	journal	October 2018
ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins de Castro, E.; Sigrist, C. J. A.; Gattiker, A. Nucleic Acids Research, Vol. 34, Issue Web Server https://doi.org/10.1093/nar/gkl124	journal	July 2006
Rational development of high-affinity T-cell receptor-like antibodies Stewart-Jones, G.; Wadle, A.; Hombach, A. Proceedings of the National Academy of Sciences, Vol. 106, Issue 14 https://doi.org/10.1073/pnas.0901425106	journal	March 2009
Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy Raman, Marine C. C.; Rizkallah, Pierre J.; Simmons, Ruth Scientific Reports, Vol. 6, Issue 1 https://doi.org/10.1038/srep18851	journal	January 2016
Monoclonal TCR-redirected tumor cell killing Liddy, Nathaniel; Bossi, Giovanna; Adams, Katherine J. Nature Medicine, Vol. 18, Issue 6 https://doi.org/10.1038/nm.2764	journal	May 2012
T cell killing does not require the formation of a stable mature immunological synapse Purbhoo, Marco A.; Irvine, Darrell J.; Huppa, Johannes B. Nature Immunology, Vol. 5, Issue 5 https://doi.org/10.1038/ni1058	journal	March 2004
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs) Stone, Jennifer D.; Aggen, David H.; Schietinger, Andrea OncoImmunology, Vol. 1, Issue 6 https://doi.org/10.4161/onci.20592	journal	September 2012
Interferons, immunity and cancer immunoediting Dunn, Gavin P.; Koebel, Catherine M.; Schreiber, Robert D. Nature Reviews Immunology, Vol. 6, Issue 11 https://doi.org/10.1038/nri1961	journal	November 2006
Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells Cameron, Brian J.; Gerry, Andrew B.; Dukes, Joseph Science Translational Medicine, Vol. 5, Issue 197 https://doi.org/10.1126/scitranslmed.3006034	journal	August 2013
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy Morgan, Richard A.; Chinnasamy, Nachimuthu; Abate-Daga, Daniel Journal of Immunotherapy, Vol. 36, Issue 2 https://doi.org/10.1097/CJI.0b013e3182829903	journal	January 2013
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant Chapuis, Aude G.; Egan, Daniel N.; Bar, Merav Nature Medicine, Vol. 25, Issue 7 https://doi.org/10.1038/s41591-019-0472-9	journal	June 2019
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer Tran, Eric; Robbins, Paul F.; Lu, Yong-Chen New England Journal of Medicine, Vol. 375, Issue 23 https://doi.org/10.1056/NEJMoa1609279	journal	December 2016
T cell-engaging therapies — BiTEs and beyond Goebeler, Maria-Elisabeth; Bargou, Ralf C. Nature Reviews Clinical Oncology, Vol. 17, Issue 7 https://doi.org/10.1038/s41571-020-0347-5	journal	April 2020
Expression of the W6/32 HLA epitope by cells of rat, mouse, human and other species: critical dependence on the interaction of specific MHC heavy chains with human or bovine β2-microglobulin Jefferies, Wilfred A.; MacPherson, G. Gordon European Journal of Immunology, Vol. 17, Issue 9 https://doi.org/10.1002/eji.1830170907	journal	January 1987
Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes Skora, Andrew D.; Douglass, Jacqueline; Hwang, Michael S. Proceedings of the National Academy of Sciences, Vol. 112, Issue 32 https://doi.org/10.1073/pnas.1511996112	journal	July 2015
CD-HIT Suite: a web server for clustering and comparing biological sequences Huang, Ying; Niu, Beifang; Gao, Ying Bioinformatics, Vol. 26, Issue 5 https://doi.org/10.1093/bioinformatics/btq003	journal	January 2010
Improving biosensor analysis Myszka, David G. Journal of Molecular Recognition, Vol. 12, Issue 5 https://doi.org/10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3	journal	September 1999
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability Niesen, Frank H.; Berglund, Helena; Vedadi, Masoud Nature Protocols, Vol. 2, Issue 9 https://doi.org/10.1038/nprot.2007.321	journal	September 2007
Thermofluor-based high-throughput stability optimization of proteins for structural studies Ericsson, Ulrika B.; Hallberg, B. Martin; DeTitta, George T. Analytical Biochemistry, Vol. 357, Issue 2 https://doi.org/10.1016/j.ab.2006.07.027	journal	October 2006
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors Cheng, Ming; Santich, Brian H.; Xu, Hong OncoImmunology, Vol. 5, Issue 6 https://doi.org/10.1080/2162402X.2016.1168557	journal	March 2016
MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells Altman, John D.; Davis, Mark M. Current Protocols in Immunology, Vol. 115, Issue 1 https://doi.org/10.1002/cpim.14	journal	November 2016
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Garboczi, D. N.; Hung, D. T.; Wiley, D. C. Proceedings of the National Academy of Sciences, Vol. 89, Issue 8 https://doi.org/10.1073/pnas.89.8.3429	journal	April 1992
Protein production by auto-induction in high-density shaking cultures Studier, F. William Protein Expression and Purification, Vol. 41, Issue 1, p. 207-234 https://doi.org/10.1016/j.pep.2005.01.016	journal	May 2005
Automated data collection for macromolecular crystallography Winter, Graeme; McAuley, Katherine E. Methods, Vol. 55, Issue 1 https://doi.org/10.1016/j.ymeth.2011.06.010	journal	September 2011
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
How good are my data and what is the resolution? Evans, Philip R.; Murshudov, Garib N. Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7 https://doi.org/10.1107/S0907444913000061	journal	June 2013
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
An in silico—in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients Mishto, Michele; Mansurkhodzhaev, Artem; Ying, Ge Frontiers in Immunology, Vol. 10 https://doi.org/10.3389/fimmu.2019.02572	journal	November 2019
Overview of the CCP 4 suite and current developments Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444910045749	journal	March 2011
Refinement of Macromolecular Structures by the Maximum-Likelihood Method Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3 https://doi.org/10.1107/S0907444996012255	journal	May 1997
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
TCR3d: The T cell receptor structural repertoire database Gowthaman, Ragul; Pierce, Brian G. Bioinformatics, Vol. 35, Issue 24 https://doi.org/10.1093/bioinformatics/btz517	journal	June 2019
A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes Pierce, Brian G.; Weng, Zhiping Protein Science, Vol. 22, Issue 1 https://doi.org/10.1002/pro.2181	journal	December 2012
Single MHC Mutation Eliminates Enthalpy Associated with T Cell Receptor Binding Miller, Peter J.; Pazy, Yael; Conti, Brian Journal of Molecular Biology, Vol. 373, Issue 2 https://doi.org/10.1016/j.jmb.2007.07.028	journal	October 2007
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes Nijman, Hans W.; Houbiers, Jos G. A.; Vierboom, Michel P. M. European Journal of Immunology, Vol. 23, Issue 6 https://doi.org/10.1002/eji.1830230603	journal	June 1993
Self-Assembly of Antibodies by Chemical Induction Li, Qing; Hapka, David; Chen, Hua Angewandte Chemie International Edition, Vol. 47, Issue 52 https://doi.org/10.1002/anie.200803507	journal	December 2008
Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells Junttila, Teemu T.; Li, Ji; Johnston, Jennifer Cancer Research, Vol. 74, Issue 19 https://doi.org/10.1158/0008-5472.CAN-13-3622-T	journal	September 2014
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19 ⁺ tumor cells Reusch, Uwe; Duell, Johannes; Ellwanger, Kristina mAbs, Vol. 7, Issue 3 https://doi.org/10.1080/19420862.2015.1029216	journal	March 2015
Crystal structure of the human T cell receptor CD3 heterodimer complexed to the therapeutic mAb OKT3 Kjer-Nielsen, L.; Dunstone, M. A.; Kostenko, L. Proceedings of the National Academy of Sciences, Vol. 101, Issue 20 https://doi.org/10.1073/pnas.0402295101	journal	May 2004
MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies Liu, Liqin; Lam, Chia-Ying K.; Long, Vatana Clinical Cancer Research, Vol. 23, Issue 6 https://doi.org/10.1158/1078-0432.CCR-16-0666	journal	September 2016

Similar Records

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

Journal Article · 2022 · Nature Medicine · OSTI ID:1872599

Chandran, Smita S.; Ma, Jiaqi; Klatt, Martin G.; +19 more

The relative radiosensitivity of TK6 and W1-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status.

Journal Article · 1995 · Mutat. Res. Lett. · OSTI ID:937741

Zhen, W; Denault, C M; Loviscek, K; +3 more

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Journal Article · 2021 · Nature Communications · OSTI ID:1875640

Hwang, Michael S.; Miller, Michelle S.; Thirawatananond, Puchong; +19 more

Related Subjects

99 GENERAL AND MISCELLANEOUS

Targeting a neoantigen derived from a common TP53 mutation

Citation Formats

References (80)

Similar Records

Related Subjects